We manufacture and provide 379270-35-6 Tenofovir Alafenamide intermediate
CAS 379270-35-6
Purity is ≥ 98%
Tenofovir Alafenamide:
is a nucleotide reverse transcriptase inhibitor and a prodrug of
tenofovir. It was developed by Gilead Sciences for use in the treatment
of HIV infection and chronic hepatitis B, and is applied in the form
of tenofovir alafenamide fumarate (TAF).